期刊文献+
共找到361篇文章
< 1 2 19 >
每页显示 20 50 100
Current understanding of glucose transporter 4 expression and functional mechanisms 被引量:2
1
作者 Tiannan Wang Jing Wang +2 位作者 Xinge Hu Xian-Ju Huang Guo-Xun Chen 《World Journal of Biological Chemistry》 CAS 2020年第3期76-98,共23页
Glucose is used aerobically and anaerobically to generate energy for cells.Glucose transporters(GLUTs)are transmembrane proteins that transport glucose across the cell membrane.Insulin promotes glucose utilization in ... Glucose is used aerobically and anaerobically to generate energy for cells.Glucose transporters(GLUTs)are transmembrane proteins that transport glucose across the cell membrane.Insulin promotes glucose utilization in part through promoting glucose entry into the skeletal and adipose tissues.This has been thought to be achieved through insulin-induced GLUT4 translocation from intracellular compartments to the cell membrane,which increases the overall rate of glucose flux into a cell.The insulin-induced GLUT4 translocation has been investigated extensively.Recently,significant progress has been made in our understanding of GLUT4 expression and translocation.Here,we summarized the methods and reagents used to determine the expression levels of Slc2a4 mRNA and GLUT4 protein,and GLUT4 translocation in the skeletal muscle,adipose tissues,heart and brain.Overall,a variety of methods such real-time polymerase chain reaction,immunohistochemistry,fluorescence microscopy,fusion proteins,stable cell line and transgenic animals have been used to answer particular questions related to GLUT4 system and insulin action.It seems that insulininduced GLUT4 translocation can be observed in the heart and brain in addition to the skeletal muscle and adipocytes.Hormones other than insulin can induce GLUT4 translocation.Clearly,more studies of GLUT4 are warranted in the future to advance of our understanding of glucose homeostasis. 展开更多
关键词 glucose transporter 4 INSULIN Skeletal muscle ADIPOCYTES BRAIN HEART ANTIBODIES
下载PDF
Effect of iron supplementation on glucose transporter 4 expression in adipose tissue and skeletal muscle of pregnant rats
2
作者 Mulan He Jing Jiang +1 位作者 Shuangping Liu Haidong Cheng 《Open Journal of Obstetrics and Gynecology》 2013年第6期500-507,共8页
Objective: The main goal of the present study was to investigate the effect of iron supplementation on glucose transporter 4 expressions in adipose tissue and skeletal muscle in female rats during pregnancy. Methods: ... Objective: The main goal of the present study was to investigate the effect of iron supplementation on glucose transporter 4 expressions in adipose tissue and skeletal muscle in female rats during pregnancy. Methods: Twenty-four pregnant Sprague-Dawley rats were randomly divided into 2 groups: a control group with a standard diet (containing iron 150 mg/kg) and an iron-supplementation group with a high-iron diet (containing iron 700 mg/kg) from day 0 to day 21 of pregnancy. Intraperitoneal glucose tolerance test was performed on gestational day 19. On gestational day 21, all of the pregnant rats from each group were sacrificed. The mean neonatal weights were measured and samples of maternal intraabdominal adipose tissue and skeletal muscle were taken to measure the expression of Glucose Transporter 4 (GLUT4) mRNA and protein. Results: Glucose tolerance decreased significantly in the iron supplementation group compared to the control group. The mean neonatal weights in the iron supplementation group were higher than that in the control group. Levels of GLUT4 mRNA in the adipose tissue were reduced by the administrations of high-iron diet. The skeletal muscle GLUT4 mRNA levels were not changed significantly by iron supplementation. Expression of GLUT4 protein both in the adipose tissue and skeletal muscle reduced significantly. Conclusion: These results suggest that iron supplementation during pregnancy would increase neonatal weights and could decrease maternal glucose tolerance by interfering GLUT4 expression in adipose tissue and skeletal muscle of rats. 展开更多
关键词 Iron Diabetes GESTATIONAL INSULIN Resistance glucose transporter Type 4 (GLUT4) Rats
下载PDF
Uses of knockout,knockdown,and transgenic models in the studies of glucose transporter 4
3
作者 Tian-Nan Wang Xin-Ge Hu Guo-Xun Chen 《World Journal of Meta-Analysis》 2022年第1期1-11,共11页
Currently,glucose transporter 4(GLUT4)has been considered as the key player for the insulin-stimulated glucose transport in the muscle and adipose tissues.The development of recombinant DNA techniques allows the creat... Currently,glucose transporter 4(GLUT4)has been considered as the key player for the insulin-stimulated glucose transport in the muscle and adipose tissues.The development of recombinant DNA techniques allows the creations of genetically knockout,knockdown and transgenic animals and cells for the study of GLUT4’s physiological functions.Here,we have used key words to search the PubMed and summarized the methods used in Slc2a4 gene knockout,GLUT4 knockdown and overexpression in the whole body and tissue specific manner.The whole body GLUT4-null mice have growth retardation,but normal glucose tolerance and basal glucose turnover rates.Compared with whole body Slc2a4 knockout mice,adipose and muscle double knockout mice have impaired insulin tolerance and glucose intolerance.The results of GLUT4 knockdown in 3T3-L1 adipocytes have shown that its expression is needed for lipogenesis after,but not during,differentiation.Transgenic mice with the whole body GLUT4 overexpression have normal body weight and lowered blood glucose level.The adipose tissue specific overexpression of GLUT4 leads to increases in mouse body weight and adipose tissue weight.The insulin-stimulated GLUT4 translocation in the skeletal muscle contributes to the regulation of glucose homeostasis.Data from both transgenic overexpression and tissue specific Slc2a4 knockout indicate that GLUT4 probably plays a role in the glucose uptake in the fasting state.More studies are warranted to use advanced molecular biology tools to decipher the roles of GLUT4 in the control of glucose homeostasis. 展开更多
关键词 glucose transporter 4 KNOCKOUT KNOCKDOWN TRANSGENE OVEREXPRESSION INSULIN
下载PDF
The expression of glucose transporter 4 in endometrium of polycystic ovary syndrome women and its change after metformin treatment
4
作者 林仙华 叶碧绿 +3 位作者 徐炳森 赵军招 林金菊 杨海燕 《生殖医学杂志》 CAS 2007年第A01期39-45,共7页
Objective:To investigate the protein and messenger RNA expression of glucose transporter 4 in endometrium of women with polycystic ovary syndrome(PCOS),and to evaluate its change after three months treatment of metfor... Objective:To investigate the protein and messenger RNA expression of glucose transporter 4 in endometrium of women with polycystic ovary syndrome(PCOS),and to evaluate its change after three months treatment of metformin.Methods:Twenty-two patients with polycystic ovary syndrome(group A)and six non-PCOS infertile women(group B)were recruited in our hospital.The consent form was obtained from each patient.Endometrium and blood samples were obtained during the proliferative phase of the menstrual cycle.Reverse transcriptase-polymerase chain reaction(RT-PCR)and immunohistochemical method were applied to detect the expression of glucose transporter 4(GLUT4)in endometrium.All PCOS patients received monotherapy of metformin after endometrium biopsy.Seven un-conceived patients(group A1)from group A who completed three months of metformin treatment were selected to perform the second time biopsy during proliferative phase.The expression of GLUT4 were remeasured as well.Results:There were no significant differences of the levels of E2,P and endometrium thickness on the biopsy day between group A and group B.But the basal levels of LH,T,LH/FSH ratio,and the ovarian volume were significantly higher in group A as compared with group B(P<0.001).The expression of GLUT4 in group A was significantly lower than that of group B(1.05±0.13 vs 1.50±0.21,P<0.001).In group A1,the expression of GLUT4 in endometrium were changed from 1.08±0.08 to 1.27±0.16 before and after treatment(P<0.05).The results of immunohistochemical staining of GLUT4 in endometrium were coincident with the results of RT-PCR.The fast insulin level and the insulin sensitivity index were also improved obviously after three months of metformin therapy(P<0.05).Conclusions:Insulin-resistance status was proved existing in endometrium of PCOS women;A significant improvement of GLUT4 expression was observed in endometrium after metformin treatment,supporting that metformin can relief insulin-resistant status of the endometrium in PCOS patients. 展开更多
关键词 葡萄糖 子宫内膜囊肿 诊断方法 临床分析
下载PDF
Expression of glucose transporter 4 in endometrium of polycystic ovary syndrome
5
作者 王玮 李晓冬 +3 位作者 郝桂敏 徐素欣 崔娜 曹金凤 《生殖医学杂志》 CAS 2008年第A01期38-44,共7页
关键词 多囊卵巢综合征 葡萄糖转运蛋白 子宫内膜 逆转录聚合酶链反应 胰岛素抵抗 基因表达 胰岛素受体 葡萄糖转运体
下载PDF
青钱柳多糖调节胰岛和肝脏葡萄糖转运蛋白4转位干预2型糖尿病大鼠的作用机制
6
作者 刘海云 石淼婷 +5 位作者 骆欣怡 孙敏燕 徐晨曦 陈鲲翰 王晓敏 舒任庚 《医药导报》 CAS 北大核心 2024年第1期13-19,共7页
目的 观察青钱柳多糖调节胰岛和肝脏葡萄糖转运蛋白4(GLUT4)转位改善2型糖尿病(T2DM)大鼠外周胰岛抵抗的作用。方法 建立T2DM大鼠模型(给予高脂饲料后注射链脲佐菌素35 mg·kg^(-1)),将造模成功的大鼠随机分为模型对照组,青钱柳多... 目的 观察青钱柳多糖调节胰岛和肝脏葡萄糖转运蛋白4(GLUT4)转位改善2型糖尿病(T2DM)大鼠外周胰岛抵抗的作用。方法 建立T2DM大鼠模型(给予高脂饲料后注射链脲佐菌素35 mg·kg^(-1)),将造模成功的大鼠随机分为模型对照组,青钱柳多糖提取物小、大剂量组(5,10 g·kg^(-1))和盐酸二甲双胍组(0.25 g·kg^(-1)),每组9只,给药8周。测定空腹血糖、血脂变化;苏木精-伊红染色法观察胰岛和肝脏病理形态的改变;免疫组化法观察胰岛磷酸化磷酯酰肌醇3激酶(p-PI3K)、磷酸化丝氨酸苏氨酸蛋白激酶1(p-Akt1)、GLUT4蛋白的表达;免疫荧光观察肝脏和胰岛GLUT4转位。结果 与模型对照组比较,青钱柳多糖提取物小、大剂量组和盐酸二甲双胍组大鼠胰岛和肝脏结构较完整,血糖下降(P<0.05),高密度脂蛋白升高(P<0.05),胰岛p-PI3K、p-Akt1、GLUT4蛋白表达升高(P<0.05),肝脏和胰岛GLUT4转位增强(P<0.05)。结论 青钱柳多糖可调节T2DM大鼠糖脂紊乱,其机制可能是增强胰岛p-PI3K、p-Akt1、GLUT4蛋白的表达,促进肝脏和胰岛GLUT4转位,从而调节外周胰岛抵抗。 展开更多
关键词 青钱柳多糖 葡萄糖转运蛋白4转位 外周胰岛素抵抗 2型糖尿病
下载PDF
妊娠糖尿病孕妇血清SOX5和GLUT4表达水平与糖脂代谢和妊娠结局的关系
7
作者 房莹 龚丽云 白利颖 《国际检验医学杂志》 CAS 2024年第9期1116-1120,1125,共6页
目的探讨SOX5、葡萄糖转运体4(GLUT4)在妊娠期糖尿病(GDM)患者血清中的表达水平及与妊娠结局的相关性。方法选取2021年1月至2023年3月该院收治的154例GDM妊娠期妇女作为GDM组,根据妊娠结局分为不良妊娠结局组(59例)和正常妊娠结局组(95... 目的探讨SOX5、葡萄糖转运体4(GLUT4)在妊娠期糖尿病(GDM)患者血清中的表达水平及与妊娠结局的相关性。方法选取2021年1月至2023年3月该院收治的154例GDM妊娠期妇女作为GDM组,根据妊娠结局分为不良妊娠结局组(59例)和正常妊娠结局组(95例),选取同期在该院进行产检的健康妊娠期妇女150例作为对照组。收集一般资料,检测血清SOX5和GLUT4表达水平;采用Pearson相关性分析GDM组妊娠期妇女血清SOX5和GLUT4与胰岛素抵抗(IR)的关系,采用受试者工作特征(ROC)曲线评价SOX5和GLUT4表达水平对不良妊娠结局的预测价值,Logistic回归分析影响不良妊娠结局发生的因素。结果GDM组患者血清GLUT4表达水平[(2.47±0.51)μg/L]低于对照组[(5.33±1.59)μg/L],GDM组患者血清SOX5表达水平[(6.53±0.96)ng/mL]高于对照组[(1.76±0.34)ng/mL],差异均有统计学意义(P<0.05);与对照组比较,GDM组妊娠期妇女血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、空腹血糖(FBG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)水平均升高,高密度脂蛋白胆固醇(HDL-C)水平下降,差异有统计学意义(P<0.05);GDM组血清SOX5表达水平与TC、TG、LDL-C、FBG、FINS、HOMA-IR呈正相关,与HDL-C表达水平呈负相关,GLUT4表达水平与TC、TG、LDL-C、FBG、FINS、HOMA-IR呈负相关,与HDL-C表达水平呈正相关(均P<0.05);不良妊娠结局组患者血清GLUT4表达水平[(1.88±0.47)μg/L]低于正常妊娠结局组[(2.84±0.54)μg/L],不良妊娠结局组患者血清SOX5表达水平[(8.02±1.05)ng/mL]高于正常妊娠结局组[(5.61±0.91)ng/mL],差异有统计学意义(P<0.05);ROC曲线结果显示,血清SOX5和GLUT4表达水平预测GDM患者不良妊娠结局的曲线下面积(AUC)分别为0.871(95%CI:0.807~0.919)、0.884(95%CI:0.822~0.930),对应的灵敏度分别为88.14%、74.58%,特异度分别为74.74%、88.42%,二者联合预测的AUC为0.940(95%CI:0.889~0.972),灵敏度为74.58%,特异度为96.84%;多因素Logistic回归分析结果显示,SOX5、TG、LDL-C、FBG、FINS、HOMA-IR均是影响不良妊娠结局发生的危险因素,GLUT4、HDL-C是影响不良妊娠结局发生的保护因素(P<0.05)。结论GDM患者血清GLUT4表达水平下降,SOX5表达水平上升,二者均为影响GDM患者不良妊娠结局发生的因素,有望成为GDM患者不良妊娠结局的有效预测指标。 展开更多
关键词 妊娠期糖尿病 葡萄糖转运体4 SOX5 妊娠结局
下载PDF
膀胱癌组织中葡萄糖转运蛋白-4、连接蛋白-4的表达及其与临床病理特征及预后的关系研究
8
作者 肖永强 李超 +1 位作者 王亚轩 李永召 《中国中西医结合外科杂志》 CAS 2024年第3期319-323,共5页
目的:探讨膀胱癌组织中葡萄糖转运蛋白-4(GLUT4)、连接蛋白-4(nectin-4)的表达及其与临床病理特征及预后的关系。方法:收集本院2018年5月—2021年8月间治疗的90例膀胱癌患者癌组织石蜡标本及其对应的癌旁正常组织石蜡标本。对比膀胱癌... 目的:探讨膀胱癌组织中葡萄糖转运蛋白-4(GLUT4)、连接蛋白-4(nectin-4)的表达及其与临床病理特征及预后的关系。方法:收集本院2018年5月—2021年8月间治疗的90例膀胱癌患者癌组织石蜡标本及其对应的癌旁正常组织石蜡标本。对比膀胱癌组织与癌旁组织中GLUT4、nectin-4的阳性表达率,分析GLUT4、nectin-4的表达与临床病理特征及预后的关系,采用COX回归模型分析患者预后的影响因素。结果:GLUT4、nectin-4在膀胱癌组织中的阳性率分别为75.56%与80.00%,高于GLUT4、nectin-4在癌旁正常组织中的阳性率(25.56%与31.11%),差异有统计学意义(P<0.05);GLUT4在膀胱癌组织中的表达情况与病理分级、临床分期及淋巴结转移有关(P<0.05);nectin-4在膀胱癌组织中的表达情况与肿瘤最大直径、病理分级、临床分期及淋巴结转移有关(P<0.05);随访至2023年10月,膀胱癌组织中GLUT4、nectin-4阳性表达患者无病中位生存时间32.52个月与34.18个月,均高于GLUT4、nectin-4阴性表达患者(26.25个月与27.47个月)(P<0.05);COX多因素回归分析结果显示,临床分期(肌层浸润)、淋巴结转移(有)、GLUT4(阳性表达)与nectin-4(阳性表达)为影响膀胱癌患者预后的独立危险因素(P<0.05)。结论:GLUT4、nectin-4在膀胱癌组织中均具有高表达,两项指标与膀胱癌患者病情发展及预后密切相关,为影响患者预后的独立危险因素。 展开更多
关键词 葡萄糖转运蛋白-4 连接蛋白-4 膀胱癌 病理特征 预后 相关性
下载PDF
A Potential Role for GLUT4 in Predicting Sepsis in Critically Ill Children
9
作者 Yanna Zhou Guangming Liu +3 位作者 Xiaohui Wu Aidi Kuang Cuiping Zhu Qiuyan Peng 《Open Journal of Internal Medicine》 2024年第1期1-15,共15页
Background: This study investigated serum Glucose transporter (GLUT) 4 levels and examined the relationship between serum GLUT4 levels and sepsis in critically ill children. Methods: This was a retrospective study of ... Background: This study investigated serum Glucose transporter (GLUT) 4 levels and examined the relationship between serum GLUT4 levels and sepsis in critically ill children. Methods: This was a retrospective study of 77 critically ill children and 33 non-diabetic healthy children (controls) who were admitted between 07/2015 and 05/2016. Patient data, clinical information, and blood samples were collected on admission, alongside a large number of laboratory parameters that were routinely assessed. Critically ill patients were divided into sepsis and non-sepsis/systemic inflammatory response syndrome (SIRS). Serum GLUT4 was measured using western blotting and enzyme-linked immunosorbent assays. Insulin resistance indexes, clinical data, laboratory parameters, and inflammatory cytokines were assessed. Results: GLUT4 serum levels were higher in critically ill children than in healthy children (90.5 vs. 30.3 μg/L, P 0.05). Compared to healthy children, hyperglycemic patients (n = 48) had elevated GLUT4 serum levels (30.3 vs. 103.7 g/L, P Conclusions: GLUT4 serum levels might be significantly increased in critically ill children compared with healthy children, particularly those in septic shock. Serum GLUT4 could predict disease severity. 展开更多
关键词 CHILDREN Critical Illness glucose transporter Type 4 HYPERGLYCEMIA Insulin Resistance
下载PDF
Anti-diabetic potential of apigenin,luteolin,and baicalein via partially activating PI3K/Akt/GLUT-4 signaling pathways in insulin-resistant HepG2 cells
10
作者 Lingchao Miao Haolin Zhang +10 位作者 Meng Sam Cheong Ruting Zhong Paula Garcia-Oliveira Miguel A.Prieto Ka-Wing Cheng Mingfu Wang Hui Cao Shaoping Nie Jesus Simal-Gandara Wai San Cheang Jianbo Xiao 《Food Science and Human Wellness》 SCIE CSCD 2023年第6期1991-2000,共10页
Dietary flavonoids are abundant in natural plants and possess multiple pharmacological and nutritional activities.In this study,apigenin,luteolin,and baicalein were chosen to evaluate their anti-diabetic effect in hig... Dietary flavonoids are abundant in natural plants and possess multiple pharmacological and nutritional activities.In this study,apigenin,luteolin,and baicalein were chosen to evaluate their anti-diabetic effect in high-glucose and dexamethasone induced insulin-resistant(IR)HepG2 cells.All flavonoids improves the glucose consumption and glycogen synthesis abilities in IR-HepG2 cells via activating glucose transporter protein 4(GLUT4)and phosphor-glycogen synthase kinase(GSK-3β).These fl avonoids signifi cantly inhibited the production of reactive oxygen species(ROS)and advanced glycation end-products(AGEs),which were closely related to the suppression of the phosphorylation form of NF-κB and P65.The expression levels of insulin receptor substrate-1(IRS-1),insulin receptor substrate-2(IRS-2)and phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)pathway in IR-HepG2 cells were all partially activated by the fl avonoids,with variable effects.Furthermore,the intracellular metabolic conditions of the fl avonoids were also evaluated. 展开更多
关键词 APIGENIN LUTEOLIN BAICALEIN Insulin-resistant HepG2 cells Signaling pathway Reactive oxygen species(ROS) Advanced glycation end-products(AGEs) Glycogen synthase kinase(GSK-3β) glucose transporter protein 4(GLUT4)
下载PDF
Effect of insulin in combination with selenium on blood glucose and GLUT4 expression in skeletal muscle of streptozotocin-induced diabetic rats 被引量:1
11
作者 Tian-jiao Xu,Bing-xiang Yuan,Ya-min Zou Department of Pharmacology,Medical School of Xi’an Jiaotong University,Xi’an 710061,China. 《Journal of Pharmaceutical Analysis》 SCIE CAS 2009年第2期86-91,共6页
Objective To evaluate the effect of low-dose insulin [1 U/(kg·d)] in combination with selenium [180 g/(kg·d)] on general physiological parameters and glucose transporter (GLUT4) level in skeletal muscle of s... Objective To evaluate the effect of low-dose insulin [1 U/(kg·d)] in combination with selenium [180 g/(kg·d)] on general physiological parameters and glucose transporter (GLUT4) level in skeletal muscle of streptozotocin (STZ)-induced diabetic rats. Methods Diabetic rats were treated with insulin,selenium,and insulin and selenium in combination for four weeks. The level of blood glucose was determined using One Touch SureStep Blood Glucose meter and the level of GLUT4 in skeletal muscle was examined by immunoblotting and immunohistochemistry. Results Our data showed that insulin in combination with selenium could significantly lower blood glucose level and restore the disturbance in GLUT4 level in skeletal muscle. Treatment with insulin was only partially effective in restoring diabetic alterations. Conclusion It can be concluded that there is a synergistic action between insulin and selenium,and that treatment of diabetic rats with combined doses of insulin and selenium is effective in the normalization of blood glucose level and correction of altered GLUT4 distribution in skeletal muscle of diabetic rats. 展开更多
关键词 streptozotocin-induced diabetes INSULIN SELENIUM glucose transporter 4 (GLUT4) skeletal muscle
下载PDF
Photoactivation of GLUT4 translocation promotes glucose uptake via PI3-K/Akt2 signaling in 3T3-L1 adipocytes
12
作者 Lei Huang Longlong Gong +1 位作者 Xiaoxiao Jiang Da Xing 《Journal of Innovative Optical Health Sciences》 SCIE EI CAS 2014年第3期12-21,共10页
Insulin resistance is a hallmark of the metabolic syndrome and type 2 diabetes.Dysfunction of PI-3K/Akt signaling was involved in insulin resistance.Glucose transporter 4(GLUT4)is a keyfactor for glucose uptake in mus... Insulin resistance is a hallmark of the metabolic syndrome and type 2 diabetes.Dysfunction of PI-3K/Akt signaling was involved in insulin resistance.Glucose transporter 4(GLUT4)is a keyfactor for glucose uptake in muscle and adipose tissues,which is closely regulated by Pi-3K/Aktsignaling in response to insulin treatment.Low-power laser irradiation(LPLI)has been shown toregulate various physiological processes and induce the synthesis or release of multiple moleculessuch as growth factors,which(especially red and near infrared light)is mainly through theactivation of mitochondrial respiratory chain and the initiation of intracellular signaling path-ways.Nevertheless,it is unclear whether LPLI could promote glucose uptake through activationof PI-3K/Akt/GLUT4 signaling in 3T3L-1 adipocytes.In this study,we investigated how LPLIpromoted glucose uptake through activation of PI-3K/Akt/GLUT4 signaling path way.Here,we showed that GLUT4 was localized to the Golgi apparatus and translocated from cytoplasm tocytomembrane upon LPLI treatment in 3T3L-1 adipocytes,which enhanced glucose uptake.Moreover,we found that glucose uptake was mediated by the PI3-K/Akt2 signaling,but notAkt1 upon LPLI treatment with Akt isoforms gene silence and PI3-K/Akt inhibitors.Collec-tively,our results indicate that PI3-K/Akt2/GLUT4 signaling act as the key regulators forimprovement of glucose uptake under LPLI treatment in 3T3L-i adipocytes.More importantly,our findings suggest that activation of PI3-K/Akt2/GLUT4 signaling by LPLI may provideguidance in practical applications for promotion of glucose uptake in insulin-resistant adiposetissue. 展开更多
关键词 glucose transporter 4 PI-3K/Akt low-power laser irradiation insulin resistance 3T3-L1 adipocytes type 2 diabetes.
下载PDF
妊娠期肝内胆汁淤积症孕妇血清PDCD4,GLUT1表达水平及其与妊娠结局的相关性研究 被引量:2
13
作者 罗亚丽 黄志刚 +1 位作者 罗思通 徐洲 《现代检验医学杂志》 CAS 2023年第3期143-148,共6页
目的检测妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy,ICP)孕妇血清程序性细胞死亡因子4(programmed cell death factor 4,PDCD4)和葡萄糖转运蛋白1(glucose transporter 1,GLUT1)的表达水平,分析二者与孕妇妊娠结局... 目的检测妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy,ICP)孕妇血清程序性细胞死亡因子4(programmed cell death factor 4,PDCD4)和葡萄糖转运蛋白1(glucose transporter 1,GLUT1)的表达水平,分析二者与孕妇妊娠结局的相关性。方法收集巴中市巴州区妇幼保健院产科2018年7月~2020年7月收治的ICP孕妇126例作为研究组,其中轻度ICP组46例,重度ICP组80例,选择同期该院120例健康产检孕妇作为对照组。采用实时荧光定量PCR(qRT-PCR)法测定ICP孕妇血清PDCD4和GLUT1水平,多因素Logistic回归分析影响ICP孕妇妊娠结局的因素,Pearson相关性分析ICP孕妇血清PDCD4和GLUT1水平的相关性。结果与对照组比较,研究组PDCD4(1.36±0.23 vs 1.02±0.21),GLUT1(1.40±0.22 vs 0.99±0.18)水平升高,差异具有统计学意义(t=15.935,12.090,均P=0.000)。重度ICP组PDCD4(1.41±0.25),GLUT1(1.45±0.22)水平显著高于轻度ICP组(1.27±0.20,1.31±0.21),差异具有统计学意义(t=3.246,3.496,均P<0.05)。研究组羊水胎粪污染(20.63%)、自发性早产(7.14%)、产后出血(8.73%)、宫内窘迫(11.90%)等不良妊娠结局的发生率均高于对照组(0.00%,0.83%,0.83%,1.67%),差异均具有统计学意义(χ^(2)=1.049~29.159,均P<0.05);妊娠结局良好组和妊娠结局不良组患者的发病程度(OR=1.109,95%CI=1.035~1.188)、PDCD4(OR=1.428,95%CI=1.013~2.012)以及GLUT1(OR=1.453,95%CI=1.066~1.980)水平差异具有统计学意义(均P<0.05);多因素Logistic回归分析显示,发病程度、PDCD4,GLUT1为ICP孕妇妊娠结局不良的影响因素(Waldχ^(2)==8.738,1.428,1.453;P=0.003,0.041,0.018);Pearson相关性分析显示,ICP孕妇血清PDCD4与GLUT1水平呈正相关(r=0.460,P<0.05)。结论PDCD4,GLUT1在ICP孕妇血清中表达均上调,二者呈正相关,是ICP孕妇妊娠结局不良的影响因素。 展开更多
关键词 妊娠期肝内胆汁淤积症 程序性细胞死亡因子4 葡萄糖转运蛋白1
下载PDF
西洋参茎叶总皂苷对胰岛素抵抗脂肪细胞葡萄糖转运、GLUT-4转位和CAP基因表达的影响 被引量:19
14
作者 殷惠军 张颖 +3 位作者 杨领海 白桂荣 史大卓 陈可冀 《中国药理学通报》 CAS CSCD 北大核心 2007年第10期1332-1337,共6页
目的观察西洋参茎叶总皂苷(PQS)对脂肪细胞胰岛素抵抗状态下葡萄糖转运、葡萄糖转运子-4(GLUT-4)转位和c-cb1结合蛋白(CAP)基因表达的影响。方法将3T3-L1前脂肪细胞诱导分化为成熟脂肪细胞,用游离脂肪酸(FFA)制备脂肪细胞胰岛素抵抗(IR... 目的观察西洋参茎叶总皂苷(PQS)对脂肪细胞胰岛素抵抗状态下葡萄糖转运、葡萄糖转运子-4(GLUT-4)转位和c-cb1结合蛋白(CAP)基因表达的影响。方法将3T3-L1前脂肪细胞诱导分化为成熟脂肪细胞,用游离脂肪酸(FFA)制备脂肪细胞胰岛素抵抗(IR)模型,液闪仪测定3H标记的葡萄糖的摄取率,免疫荧光法检测GLUT-4转位,用逆转录-聚合酶链反应(RT-PCR)法检测培养细胞中CAPmRNA的表达。结果模型组胰岛素刺激下的葡萄糖转运率明显低于正常对照组(P<0.01);与模型组相比,二甲双胍组、PQS大/中剂量组葡萄糖转运率明显增加(P<0.01、P<0.01、P<0.05),但PQS小剂量组作用不明显。正常对照组在胰岛素刺激前,GLUT-4大部分位于胞质内,胰岛素刺激30min后,胞质内的分布较刺激前明显减少,胞膜周围的分布相对增加;而模型组在胰岛素刺激前后,GLUT-4在细胞内的分布无变化;但在二甲双胍组和PQS3个剂量组的结果显示,胰岛素刺激后,胞质内GLUT-4分布减少,胞膜周围的分布相对增加。模型组CAPmRNA水平较正常组明显下降(P<0.05);与模型组相比,二甲双胍和PQS大、中剂量组CAPmRNA水平明显上升(P<0.01),PQS小剂量未见明显效果。结论PQS可改善脂肪细胞IR,这可能与其促进脂肪细胞CAP基因转录、GLUT-4转位和葡萄糖转运有关。 展开更多
关键词 西洋参茎叶总皂苷 313-L1脂肪细胞 葡萄糖转运子4转位 c-cbl结合蛋白基因表达
下载PDF
miR-93-5p对胰岛素抵抗细胞模型中HGF、GLUT4表达及GLUT4分布的影响
15
作者 周曼 吴军 +4 位作者 干定云 陈婉 曹萍 李广利 侯以琳 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2023年第6期823-827,共5页
目的探讨miR-93-5p对胰岛素抵抗细胞模型中肝细胞生长因子(hepatocyte growth factor,HGF)、葡萄糖转运蛋白4(glucose transporter 4,GLUT4)表达及GLUT4分布的影响。方法将细胞分为对照组、模型组、miR-93-5p inhibitor组、inhibitor-N... 目的探讨miR-93-5p对胰岛素抵抗细胞模型中肝细胞生长因子(hepatocyte growth factor,HGF)、葡萄糖转运蛋白4(glucose transporter 4,GLUT4)表达及GLUT4分布的影响。方法将细胞分为对照组、模型组、miR-93-5p inhibitor组、inhibitor-NC组、miR-93-5p mimics组和mimics-NC组。对照组细胞正常培养,模型组构建胰岛素抵抗细胞模型,其余组分别转染miR-93-5p inhibitor、inhibitor-NC、miR-93-5p mimics、mimics-NC,转染完成后构建胰岛素抵抗模型。CCK-8检测细胞存活率;试剂盒检测细胞上清液中葡萄糖含量,计算葡萄糖消耗量;qPCR检测miR-93-5p、HGF、GLUT4的mRNA表达水平;Western blot检测HGF、GLUT4蛋白表达水平;免疫荧光检测GLUT4的表达和分布。结果与对照组相比,模型组细胞存活率、葡萄糖消耗量、HGF、GLUT4 mRNA和蛋白表达水平均显著降低(均P<0.01),miR-93-5p水平显著升高(P<0.01),GLUT4膜分布减少。与模型组相比,miR-93-5p inhibitor组细胞存活率、葡萄糖消耗量、HGF、GLUT4 mRNA和蛋白表达水平均显著升高(均P<0.05),miR-93-5p水平显著降低(P<0.01),GLUT4膜分布增多;mimics组结果相反。结论miR-93-5p能够抑制胰岛素抵抗细胞模型中HGF和GLUT4的表达,并减少GLUT4的膜分布,具有促进胰岛素抵抗的功能。 展开更多
关键词 胰岛素抵抗 miR-93-5p 肝细胞生长因子 葡萄糖转运蛋白4
下载PDF
肥胖Wistar大鼠骨骼肌细胞GLUT-4转位变化的研究 被引量:4
16
作者 邱忠霞 王涤非 张锦 《中国医科大学学报》 CAS CSCD 北大核心 2005年第4期297-298,共2页
目的:探讨肥胖大鼠骨骼肌细胞的葡萄糖转运因子4(GLUT-4)转位变化。方法:10周龄雄性Wistar大鼠46只,随机平均分成对照组和肥胖组。6周肥胖模型建立后,用超速蔗糖梯度离心方法分离骨骼肌细胞内膜和外膜的匀浆,用Westernblot方法检测两组... 目的:探讨肥胖大鼠骨骼肌细胞的葡萄糖转运因子4(GLUT-4)转位变化。方法:10周龄雄性Wistar大鼠46只,随机平均分成对照组和肥胖组。6周肥胖模型建立后,用超速蔗糖梯度离心方法分离骨骼肌细胞内膜和外膜的匀浆,用Westernblot方法检测两组大鼠骨骼肌细胞内、外膜GLUT-4的蛋白水平。同时分别检测其空腹血糖、空腹胰岛素和血脂浓度。结果:肥胖组大鼠的胰岛素敏感指数明显下降(P<0.01),肥胖组的内、外膜GLUT-4蛋白含量均较对照组下降,而且外膜GLUT-4下降比内膜更明显(分别为57.0%、12.2%,P<0.01)。结论:肥胖下调骨骼肌细胞GLUT-4总量,抑制细胞内膜GLUT-4向细胞外膜的转位,提示肥胖大鼠的骨骼肌存在由于GLUT-4下降调节所致的胰岛素抵抗。 展开更多
关键词 肥胖 葡萄糖转运因子4 胰岛素抵抗
下载PDF
Akt和GLUT-4在妊娠糖尿病与孕期体重过度增长孕妇脂肪组织中的表达变化 被引量:4
17
作者 伍丽 周玮 刘建 《解放军医学杂志》 CAS CSCD 北大核心 2014年第10期819-822,共4页
目的研究妊娠糖尿病(GDM)患者、体重过度增长孕妇以及正常孕妇脂肪组织中葡萄糖转运蛋白4(GLUT-4)、蛋白激酶B(Akt)的表达情况,探讨其在GDM发病过程中的作用。方法选择2013年2-7月在重庆医科大学附属第二医院行剖宫产分娩的孕妇45例作... 目的研究妊娠糖尿病(GDM)患者、体重过度增长孕妇以及正常孕妇脂肪组织中葡萄糖转运蛋白4(GLUT-4)、蛋白激酶B(Akt)的表达情况,探讨其在GDM发病过程中的作用。方法选择2013年2-7月在重庆医科大学附属第二医院行剖宫产分娩的孕妇45例作为研究对象,其中15例GDM孕妇作为GDM组,15例糖耐量正常、体重指数(BMI)增加约4kg/m2的正常孕妇作为NGT1组,15例糖耐量正常、BMI增加约8kg/m2的孕妇作为体重过度增长(NGT2)组。采集3组患者空腹外周血,检测空腹血糖(FBG)、空腹胰岛素(FINS)水平,计算胰岛素抵抗指数(HOMA-IR)和胰岛β细胞分泌指数(HOMA-IS)。行剖宫产手术时取腹部皮下脂肪组织,在含胰岛素(1×10-7mol/L)的培养液中温育30min模拟胰岛素刺激状态,以不含胰岛素培养液温育组织作为对照,采用Western blotting检测Akt的磷酸化蛋白表达和GLUT-4表达水平的变化。结果 NGT1组、NGT2组、GDM组FBG无明显差异(P>0.05);GDM组FINS、HOMA-IR、HOMA-IS均高于NGT2组,且NGT2组高于NGT1组(P<0.05)。蛋白表达检测结果显示,基础状态的脂肪组织中,3组Akt蛋白表达无明显差异(P>0.05);经胰岛素刺激后,NGT2组和GDM组Akt蛋白的磷酸化程度无明显变化(P>0.05),而NGT1组明显增加(P<0.05)。基础状态的脂肪组织中,GDM组和NGT2组GLUT-4蛋白表达均低于NGT1组,其中GDM组最低(P<0.05);经胰岛素刺激后,各组GLUT-4蛋白表达均增加,NGT1组的增幅高于NGT2组(P<0.05)。结论胰岛素信号通路中的关键分子Akt和GLUT-4的表达在孕期体重过度增长的孕妇和GDM患者中有相似变化,其表达及功能障碍可能是导致胰岛素抵抗和GDM的分子机制。 展开更多
关键词 糖尿病 妊娠 胰岛素 信号传导 葡萄糖转运体4 人体质量指数
下载PDF
有氧运动与六味地黄丸对实验性糖尿病大鼠骨骼肌GLUT-4基因表达的影响 被引量:1
18
作者 李平 运乃茹 +2 位作者 杨琳 徐倩 谭俊珍 《天津中医药大学学报》 CAS 2009年第4期195-197,共3页
[目的]研究有氧运动与六味地黄丸对糖尿病大鼠血糖、胰岛素、葡萄糖转运蛋白-4(GLUT-4)基因表达的影响。[方法]40只雄性Wistar大鼠尾静脉注射四氧嘧啶复制糖尿病动物模型。将成模的糖尿病大鼠按血糖和体质量随机分为糖尿病组、运动组、... [目的]研究有氧运动与六味地黄丸对糖尿病大鼠血糖、胰岛素、葡萄糖转运蛋白-4(GLUT-4)基因表达的影响。[方法]40只雄性Wistar大鼠尾静脉注射四氧嘧啶复制糖尿病动物模型。将成模的糖尿病大鼠按血糖和体质量随机分为糖尿病组、运动组、六味地黄丸组、运动+六味地黄丸组,同时设立正常对照组,6周后测定空腹血糖、血清胰岛素水平,逆转录-聚合酶链反应(RT-PCR)半定量测定骨骼肌GLUT-4mRNA表达。[结果]糖尿病组大鼠血糖显著升高,GLUT-4mRNA含量显著降低;补充六味地黄丸和有氧运动干预后血糖显著下降,GLUT-4mRNA含量显著增加。[结论]有氧运动和六味地黄丸能改善糖尿病大鼠糖代谢,降糖机制可能与增加骨骼肌GLUT-4mRNA的表达有关。 展开更多
关键词 糖尿病 有氧运动 glut-4 六味地黄丸 骨骼肌
下载PDF
NF-κB、GLUT-4在妊娠期糖尿病大鼠子宫内膜组织中的表达及意义 被引量:1
19
作者 魏波 李佳 +1 位作者 塔娜 陈必良 《实用妇产科杂志》 CAS CSCD 北大核心 2010年第11期836-839,I0001,共5页
目的:探讨链脲霉素(STZ)诱导妊娠期糖尿病大鼠模型子宫内膜组织中核转录因子-κB(NF-κB)及葡萄糖转运蛋白4(GLUT-4)的表达变化及其在子宫胰岛素抵抗发生中的作用。方法:40只SD孕鼠随机分为两组,妊娠期糖尿病模型组(20只)给予一次性腹... 目的:探讨链脲霉素(STZ)诱导妊娠期糖尿病大鼠模型子宫内膜组织中核转录因子-κB(NF-κB)及葡萄糖转运蛋白4(GLUT-4)的表达变化及其在子宫胰岛素抵抗发生中的作用。方法:40只SD孕鼠随机分为两组,妊娠期糖尿病模型组(20只)给予一次性腹腔注射STZ(45mg/kg),3天后监测空腹血糖和体重。正常妊娠对照组(20只)注射等量柠檬酸钠缓冲液。于分娩前即妊娠20天测定空腹血糖、体重后处死大鼠,并取材,采用免疫组化法检测子宫内膜组织中NF-κB、GLUT-4蛋白表达。结果:与正常妊娠对照组相比,妊娠期糖尿病模型组注射STZ后出现"三多一少"现象,3天后大鼠血糖明显上升(P<0.01),体重明显下降(P<0.01);子宫内膜组织NF-κB蛋白表达率升高(P<0.05),GLUT-4蛋白表达率下降(P<0.05)。结论:子宫内膜组织中NF-κB表达增高,GLUT-4表达减弱与妊娠期糖尿病子宫胰岛素抵抗相关。 展开更多
关键词 核因子-κB 葡萄糖转运蛋白4 链脲霉素 妊娠期糖尿病 胰岛素抵抗
下载PDF
抑制P53上调GLUT4改善高糖合并缺血缺氧诱导的心肌细胞糖代谢紊乱及减轻细胞凋亡 被引量:2
20
作者 张冀鑫 刘芬 +4 位作者 张桐 张雪鹤 房彬彬 李晓梅 杨毅宁 《中国动脉硬化杂志》 CAS 2023年第3期212-217,共6页
[目的]探讨抑制心肌细胞P53,增加葡萄糖转运体4(GLUT4)表达,能否改善高糖(HG)合并缺血缺氧(IH)诱导的心肌细胞糖代谢紊乱,减轻细胞凋亡。[方法]建立体外HG+IH心肌细胞模型,实验分为:对照组、HG组、IH组、HG+IH组、HG+IH+P53抑制剂组(HG+... [目的]探讨抑制心肌细胞P53,增加葡萄糖转运体4(GLUT4)表达,能否改善高糖(HG)合并缺血缺氧(IH)诱导的心肌细胞糖代谢紊乱,减轻细胞凋亡。[方法]建立体外HG+IH心肌细胞模型,实验分为:对照组、HG组、IH组、HG+IH组、HG+IH+P53抑制剂组(HG+IH+Pifithrin-α组)、HG+IH+P53抑制剂+GLUT4抑制剂组(HG+IH+Pifithrin-α+Fasentin组)。CCK-8法检测细胞活力,试剂盒检测乳酸脱氢酶(LDH)、糖酵解关键酶活性和ATP含量,Western blot检测P53、GLUT4、Bax/Bcl-2和Caspase-3的蛋白表达,流式细胞仪检测心肌细胞凋亡。[结果](1)体外HG+IH心肌细胞模型中,与对照组比较,心肌细胞P53表达增加75%,GLUT4表达减少16%,细胞ATP含量下降51%,细胞活力减低45%,LDH活性增加3.6倍,Caspase-3和Bax/Bcl-2表达分别增加54%和77%,细胞凋亡率增加(P均<0.05)。(2)抑制心肌细胞P53表达后,与HG+IH组比较,HG+IH+Pifithrin-α组心肌细胞GLUT4表达增加34%,细胞ATP含量增加60%,细胞活力增加50%,LDH活性减低13%,Caspase-3和Bax/Bcl-2表达分别减少31%和53%,细胞凋亡率下降(P均<0.05)。(3)在抑制GLUT4后,与HG+IH+Pifithrin-α组比较,HG+IH+Pifithrin-α+Fasentin组GLUT4表达减少22%,细胞内ATP含量减少39%,细胞存活力减低25%,LDH活性增加21%,Caspase-3和Bax/Bcl-2表达分别增加43%和89%,细胞凋亡率增加(P均<0.05)。[结论]在高糖合并缺血缺氧心肌细胞模型中,抑制P53可增加GLUT4表达,改善高糖合并缺血缺氧诱导的心肌细胞糖代谢紊乱,减轻细胞凋亡。 展开更多
关键词 P53 葡萄糖转运体4 高糖合并缺血缺氧 糖代谢紊乱 细胞凋亡
下载PDF
上一页 1 2 19 下一页 到第
使用帮助 返回顶部